The University of Nottingham is organising this study. It is being conducted by a research team led by Professor Abhishek, a Consultant Rheumatologist, and Professor Rosemary Boyton, a leading scientist in infection. The study is also being supported by a nationally accredited Clinical Trial Unit called the Oxford Clinical Trials Research Unit (OCTRU), based at the University of Oxford.
The study has been funded by the National Institute for Health Research and is sponsored by the University of Nottingham.
The VROOM study has now closed to recruitment.
To hear about the study from one of the study's doctors - watch a short video about it by clicking here.
5 April 2023
The VROOM study has been mentioned in the latest edition of COVID-19: The Green Book issued by the UK Health Security Agency. To read the relevant chapter, please follow the link here.
26 January 2022
The NIHR (National Institute for Health and Care Research) has issued an alert summarizing the initial findings of the VROOM study here: A pause in methotrexate treatment boosted the immune response to the COVID-19 vaccine.
12 July 2022
News Item 2
What has the VROOM study found so far? A lay summary of the initial findings is now available, please click here to read.
News Item 1
The interim results from the VROOM study have been published in The Lancet Respiratory Medicine Journal. The article is free for everyone to read, please click here to read the full article. A lay summary of the initial results is available here.
We hope to enrol 560 adults aged 18 years or older who have inflammatory conditions such as rheumatoid arthritis, psoriasis and psoriatic arthritis into this study. We will recruit from at least 20 NHS hospitals or centres providing NHS care.
*Please note - the VROOM study has now closed to recruitment.*